These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4678322)

  • 1. Atypical measles. Severe illness in recipients of killed measles virus vaccine upon exposure to natural infection.
    Brodsky AL
    JAMA; 1972 Dec; 222(11):1415-6. PubMed ID: 4678322
    [No Abstract]   [Full Text] [Related]  

  • 2. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of Edmonston-B and Schwarz measles vaccine in Malian children.
    Jean-Joseph P; Sow S; Casey HL; Imperato PJ; Henderson RH; Noble J
    Lancet; 1969 Mar; 1(7596):665-7. PubMed ID: 4179897
    [No Abstract]   [Full Text] [Related]  

  • 4. Measles vaccine reactions in a virgin population.
    Black FL; Woodall JP; Pinheiro FD
    Am J Epidemiol; 1969 Feb; 89(2):168-75. PubMed ID: 5765956
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical measles in children previously immunized with attenuated measles virus vaccines.
    Cherry JD; Feigin RD; Lobes LA; Shackelford PG
    Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
    [No Abstract]   [Full Text] [Related]  

  • 6. Measles in children previously vaccinated against measles.
    Lerman SJ; Gold E
    JAMA; 1971 May; 216(8):1311-4. PubMed ID: 4102807
    [No Abstract]   [Full Text] [Related]  

  • 7. Measles vaccine efficacy determined from secondary attack rates during a severe epidemic.
    McCormick JB; Halsey N; Rosenberg R
    J Pediatr; 1977 Jan; 90(1):13-6. PubMed ID: 830878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A seroepidemiologic study of a measles epidemic in a highly immunized population.
    Linnemann CC; Rotte TC; Schiff GM; Youtsey JL
    Am J Epidemiol; 1972 Mar; 95(3):238-46. PubMed ID: 5010820
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiological investigations on measles in unvaccinated and vaccinated children (author's transl)].
    Wiedermann G; Ambrosch F
    Wien Klin Wochenschr; 1976 Sep; 88(17):545-54. PubMed ID: 997537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of measles vaccination using the live measles virus vaccine SSW-L 16 on the complication rate in measles].
    Heidel G; Olbricht H; Ely K; Henkler J
    Z Arztl Fortbild (Jena); 1972 Feb; 66(3):171-4. PubMed ID: 5047088
    [No Abstract]   [Full Text] [Related]  

  • 13. Urban measles in the vaccine era: a clinical, epidemiologic, and serologic study.
    Cherry JD; Feigin RD; Lobes LA; Hinthorn DR; Shackelford PG; Shirley RH; Lins RD; Choi SC
    J Pediatr; 1972 Aug; 81(2):217-30. PubMed ID: 5042481
    [No Abstract]   [Full Text] [Related]  

  • 14. Measles and measles vaccination in isolated Amerindian tribes. II. The 1978/79 Xingu epidemic.
    Baruzzi RG; Abdala N; Black FL
    Trop Geogr Med; 1982 Mar; 34(1):7-12. PubMed ID: 7080192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical epidemiology of sporadic measles in a highly immunized population.
    Schaffner W; Schluederberg AE; Byrne EB
    N Engl J Med; 1968 Oct; 279(15):783-9. PubMed ID: 5676221
    [No Abstract]   [Full Text] [Related]  

  • 17. Observation of the protective effect of live measles vaccines in the first year after vaccination.
    Sejda J; Helcl J; Strauss J
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(3):288-95. PubMed ID: 4161911
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract]   [Full Text] [Related]  

  • 19. MEASLES VACCINATION. II. ANTIBODY TITERS 8 TO 9 MONTHS AFTER VACCINATION WITH AN INACTIVATED VACCINE.
    NORRBY E; CARLSTROEM G; LAGERCRANTZ R; GARD S
    Acta Paediatr (Stockh); 1964 Nov; 53():533-40. PubMed ID: 14225879
    [No Abstract]   [Full Text] [Related]  

  • 20. [Measles vaccination of pre-school children: a detailed study of reaction frequency and side effects after immunization with vaccine of 3 different strengths].
    Böttiger M; Heller L; Kamensky P; Svanberg B
    Lakartidningen; 1974 Sep; 71(36):3270-4. PubMed ID: 4410083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.